OIG September 2017 Summary:
“Drug Supply Chain Security: Wholesalers Exchange Most Tracing Information”
The Office of Inspector General (OIG) issued its first in a series of examinations of drug supply chain security that will outline provisions for the implementation the Drug Supply Chain Security Act (DSCSA).
This Report Discusses:
- The Office of Inspector General’s methodology
- Key findings from the report
- Recommendations based on The FDA & The OIG’s findings
Want to read the entire article?
Sign up now to view the document.
Excellis is committed to protecting your privacy and personal information. All information will be kept confidential.